Skip to main content
Home ESG Stocks
CONMED Corporation (CNMD) Stock Analysis & ESG Ratings
CNMD

CONMED Corporation

Market Price
$90.46
24h Change
+1.86%
Market Cap
$3.68B
P/E Ratio
N/A

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

MSCI ESG Rating

67.4 / 100

MSCI ESG industry rating benchmark.

Sustainalytics Risk Score

N/A

Sustainability Strengths & Catalysts (Pros)

  • Established product portfolio in surgical devices with global distribution supports resilience and enables investment in product stewardship and safety programs.
  • Public disclosure of ESG and sustainability information on the corporate website indicates a coordinated approach to environmental, social and governance matters and stakeholder engagement.
  • Regular regulatory and quality reporting inherent to medical device manufacturing drives attention to product quality, patient safety and compliance systems across operations.

Material Risks & Governance Concerns (Cons)

  • Exposure to medical device regulatory risk and product safety litigation is an ongoing ESG concern given the nature of surgical devices and potential patient safety incidents.
  • Like many manufacturing firms, CONMED faces environmental footprint risks from manufacturing operations and supply chains; third-party ESG providers note areas for improvement in environmental and social disclosures.

Company Profile & Business Model Overview

Financial & Valuation Fundamentals

Earnings Per Share (EPS)
$17.66
Dividend Yield
1.34%
Previous Close
$90.03
Day Open
$89.20

Data Integrity & Methodology Disclosure

Stock prices and market fundamentals are refreshed via our automated 04:00 UTC pipeline. ESG evaluations aggregate published ratings from MSCI ESG Research and Sustainalytics with normalized industry peer adjustments. Learn more in our ESG Rating Methodology.